English
Back
Download
Log in to access Online Inquiry
Back to the Top

Moomoo, why aren’t you reporting this FDA approval? Are you shorting it? NEWS came out at approximately 12PM ET so it is highly unlikely you didnt get the news.

“Arcutis Biotherapeutics Announces FDA Approval Of Supplemental New Drug Application For Zoryve (Roflumilast)
Cream 0.15% To Treat Mild To Moderate Atopic Dermatitis In Adults And Children 6 And Older” - Benzinga
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
5
2
+0
4
Translate
Report
4605 Views
Comment
Sign in to post a comment
Spread kindness and love. Life is short. Don’t let greed eat you.
8982
Followers
54
Following
107K
Visitors
Follow